MB
Mark Breidenbach
#1337 out of 1699 analysts
Oppenheimer
Automatically Tracked
Analyst ratings are aggregated from multiple third-party sources and may be inaccurate, incomplete, or outdated. All ratings remain the sole responsibility of their original providers. Rankings are based on the 3-year performance of a simulated $100,000 account trading on analyst ratings data.
Gain and growth charts are calculated per selected timeframe:
-11.19%
Gain 0%
Monthly
0.35%
Yearly
4.29%
Drawdown
71.21%
$1.22M
Equity
Holdings
$661,182.64
Cash
$554,216.55
Investment
$330,595.93
$367,851.94
Profit +$27.65
Realized
$37,265.23
Unrealized
$330,586.71
Dividends
$0
$554,216.55
Cash
Deposits
$847,547.24
Withdrawals
$0
Commissions
$0
Goals
Avg. 0% completed goals
Today
Compared To Yesterday
Gain
0.003%
Profit
$27.65
Win %
41%
This Week
Compared To Last Week
Gain
0.001%
Profit
$9.22
Win %
41%
This Month
Compared to last month
Gain
0.001%
Profit
$9.22
Win %
41%
This Year
Compared to last year
Gain
0.002%
Profit
$23.04
Win %
41%
No Data
SYRS Syros Pharmaceuticals Inc.
-75%
+$27.65 Events
Loading...
Dividends
Dividend Analysis
Loading...
No Data
| Trades 240 | Longs Won 77/231 33% | Profit Factor 1.3 |
| Profitability | Shorts Won 8/9 88% | Standard Deviation $26,669.88 |
| Average Win $18,754.63 | Best Trade (Jul 09) $174,360.04 | Sharpe Ratio -121.97 |
| Average Loss -$7,911.56 | Worst Trade (Jun 29) -$75,428.52 | Z-Score -0.89 (62.66%) |
| Commissions $0 | Avg. Trade Length 4m 5d | Expectancy $1,532.72 |
| Loss Size | 100% | 90% | 80% | 70% | 60% | 50% | 40% | 30% | 20% | 10% |
| Probability of Loss | <0.01% | <0.01% | 0.02% | 0.2% | 0.87% | 2.76% | 7.09% | 15.76% | 31.48% | 57.94% |
| Consecutive Losing Trades | 154 | 138 | 123 | 108 | 92 | 77 | 61 | 46 | 31 | 15 |
Hover over the desired column for a detailed explanation.
Returns
Overall, MonthlyNo Data
Option values are updated at end of day.
No Data
No Data
Option values are updated at end of day.
No Data
No Data
No Data
No Data
